Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
Upgrades
Craig-Hallum upgraded the previous rating for Carrols Restaurant Group Inc (NASDAQ:TAST) from Hold to Buy. In the fourth quarter, Carrols Restaurant Group showed an EPS of $0.05, compared to $0.15 from the year-ago quarter. The current stock performance of Carrols Restaurant Group shows a 52-week-high of $2.69 and a 52-week-low of $1.28. Moreover, at the end of the last trading period, the closing price was at $2.15.
For Delta Air Lines Inc (NYSE:DAL), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Delta Air Lines had an EPS of $1.48, compared to year-ago quarter EPS of $0.22. At the moment, the stock has a 52-week-high of $46.27 and a 52-week-low of $27.20. Delta Air Lines closed at $38.46 at the end of the last trading period.
According to Argus Research, the prior rating for DraftKings Inc (NASDAQ:DKNG) was changed from Hold to Buy. DraftKings earned $0.53 in the fourth quarter, compared to $0.80 in the year-ago quarter. The stock has a 52-week-high of $22.11 and a 52-week-low of $9.77. At the end of the last trading period, DraftKings closed at $19.19.
For United Airlines Holdings Inc (NASDAQ:UAL), Exane BNP Paribas upgraded the previous rating of Underperform to Outperform. For the fourth quarter, United Airlines Holdings had an EPS of $2.46, compared to year-ago quarter EPS of $1.60. At the moment, the stock has a 52-week-high of $53.86 and a 52-week-low of $30.54. United Airlines Holdings closed at $52.44 at the end of the last trading period.
Northcoast Research upgraded the previous rating for Costco Wholesale Corp (NASDAQ:COST) from Neutral to Buy. Costco Wholesale earned $3.30 in the second quarter, compared to $2.92 in the year-ago quarter. At the moment, the stock has a 52-week-high of $612.27 and a 52-week-low of $406.51. Costco Wholesale closed at $483.08 at the end of the last trading period.
Morgan Stanley upgraded the previous rating for ACM Research Inc (NASDAQ:ACMR) from Underweight to Overweight. For the fourth quarter, ACM Research had an EPS of $0.19, compared to year-ago quarter EPS of $0.27. The current stock performance of ACM Research shows a 52-week-high of $82.83 and a 52-week-low of $5.46. Moreover, at the end of the last trading period, the closing price was at $11.85.
For Mercantile Bank Corp (NASDAQ:MBWM), Piper Sandler upgraded the previous rating of Neutral to Overweight. Mercantile Bank earned $1.37 in the fourth quarter, compared to $0.74 in the year-ago quarter. At the moment, the stock has a 52-week-high of $39.03 and a 52-week-low of $29.26. Mercantile Bank closed at $34.09 at the end of the last trading period.
For Esperion Therapeutics Inc (NASDAQ:ESPR), Credit Suisse upgraded the previous rating of Underperform to Neutral. Esperion Therapeutics earned $0.76 in the fourth quarter, compared to $1.77 in the year-ago quarter. At the moment, the stock has a 52-week-high of $8.87 and a 52-week-low of $3.81. Esperion Therapeutics closed at $5.08 at the end of the last trading period.
For NuStar Energy LP (NYSE:NS), Stifel upgraded the previous rating of Hold to Buy. NuStar Energy earned $0.34 in the fourth quarter, compared to $0.14 in the year-ago quarter. The current stock performance of NuStar Energy shows a 52-week-high of $17.75 and a 52-week-low of $12.80. Moreover, at the end of the last trading period, the closing price was at $16.12.
For Kimbell Royalty Partners LP (NYSE:KRP), Keybanc upgraded the previous rating of Sector Weight to Overweight. In the fourth quarter, Kimbell Royalty Partners showed an EPS of $0.48, compared to $0.44 from the year-ago quarter. The current stock performance of Kimbell Royalty Partners shows a 52-week-high of $20.08 and a 52-week-low of $14.48. Moreover, at the end of the last trading period, the closing price was at $16.30.
See all analyst ratings upgrades.
Downgrades
Barrington Research downgraded the previous rating for Anika Therapeutics Inc (NASDAQ:ANIK) from Outperform to Market Perform. In the fourth quarter, Anika Therapeutics showed an EPS of $0.21, compared to $0.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of $32.51 and a 52-week-low of $19.95. Anika Therapeutics closed at $28.87 at the end of the last trading period.
Stephens & Co. downgraded the previous rating for CareDx Inc (NASDAQ:CDNA) from Overweight to Equal-Weight. CareDx earned $0.07 in the fourth quarter, compared to $0.03 in the year-ago quarter. The current stock performance of CareDx shows a 52-week-high of $41.50 and a 52-week-low of $8.10. Moreover, at the end of the last trading period, the closing price was at $10.65.
For SES AI Corp (NYSE:SES), RBC Capital downgraded the previous rating of Outperform to Sector Perform. The current stock performance of SES AI shows a 52-week-high of $10.18 and a 52-week-low of $2.87. Moreover, at the end of the last trading period, the closing price was at $3.00.
BMO Capital downgraded the previous rating for Qualtrics International Inc (NASDAQ:XM) from Outperform to Market Perform. For the fourth quarter, Qualtrics International had an EPS of $0.03, compared to year-ago quarter EPS of $0.07. The current stock performance of Qualtrics International shows a 52-week-high of $30.95 and a 52-week-low of $9.32. Moreover, at the end of the last trading period, the closing price was at $17.26.
Northcoast Research downgraded the previous rating for Trimble Inc (NASDAQ:TRMB) from Neutral to Sell. In the fourth quarter, Trimble showed an EPS of $0.60, compared to $0.62 from the year-ago quarter. The stock has a 52-week-high of $74.87 and a 52-week-low of $47.52. At the end of the last trading period, Trimble closed at $53.05.
According to Baird, the prior rating for Embark Technology Inc (NASDAQ:EMBK) was changed from Outperform to Neutral. The current stock performance of Embark Technology shows a 52-week-high of $384.00 and a 52-week-low of $2.02. Moreover, at the end of the last trading period, the closing price was at $2.56.
For Joby Aviation Inc (NYSE:JOBY), Deutsche Bank downgraded the previous rating of Hold to Sell. In the fourth quarter, Joby Aviation showed an EPS of $0.11, compared to $0.01 from the year-ago quarter. At the moment, the stock has a 52-week-high of $7.15 and a 52-week-low of $3.15. Joby Aviation closed at $4.50 at the end of the last trading period.
MoffettNathanson downgraded the previous rating for Lightspeed Commerce Inc (NYSE:LSPD) from Outperform to Market Perform. For the third quarter, Lightspeed Commerce had an EPS of $0.00, compared to year-ago quarter EPS of $0.07. The current stock performance of Lightspeed Commerce shows a 52-week-high of $34.14 and a 52-week-low of $12.71. Moreover, at the end of the last trading period, the closing price was at $15.37.
For Gossamer Bio Inc (NASDAQ:GOSS), Raymond James downgraded the previous rating of Outperform to Market Perform. In the third quarter, Gossamer Bio showed an EPS of $0.65, compared to $0.80 from the year-ago quarter. The current stock performance of Gossamer Bio shows a 52-week-high of $15.20 and a 52-week-low of $1.57. Moreover, at the end of the last trading period, the closing price was at $1.74.
HC Wainwright & Co. downgraded the previous rating for Aptinyx Inc (NASDAQ:APTX) from Buy to Neutral. In the third quarter, Aptinyx showed an EPS of $0.23, compared to $0.31 from the year-ago quarter. The current stock performance of Aptinyx shows a 52-week-high of $3.17 and a 52-week-low of $0.17. Moreover, at the end of the last trading period, the closing price was at $0.19.
HC Wainwright & Co. downgraded the previous rating for TCR2 Therapeutics Inc (NASDAQ:TCRR) from Buy to Neutral. TCR2 Therapeutics earned $0.79 in the third quarter, compared to $0.69 in the year-ago quarter. The stock has a 52-week-high of $3.88 and a 52-week-low of $0.82. At the end of the last trading period, TCR2 Therapeutics closed at $1.62.
For Ovintiv Inc (NYSE:OVV), BMO Capital downgraded the previous rating of Outperform to Market Perform. In the fourth quarter, Ovintiv showed an EPS of $0.91, compared to $1.25 from the year-ago quarter. The current stock performance of Ovintiv shows a 52-week-high of $63.30 and a 52-week-low of $37.27. Moreover, at the end of the last trading period, the closing price was at $44.01.
RBC Capital downgraded the previous rating for Office Properties Income Trust (NASDAQ:OPI) from Sector Perform to Underperform. Office Props IT earned $1.13 in the fourth quarter, compared to $1.20 in the year-ago quarter. The current stock performance of Office Props IT shows a 52-week-high of $26.22 and a 52-week-low of $12.17. Moreover, at the end of the last trading period, the closing price was at $16.89.
According to Jefferies, the prior rating for Radius Global Infrastructure Inc (NASDAQ:RADI) was changed from Buy to Hold. Radius Global Infr earned $0.23 in the third quarter, compared to $0.11 in the year-ago quarter. At the moment, the stock has a 52-week-high of $16.52 and a 52-week-low of $7.97. Radius Global Infr closed at $14.56 at the end of the last trading period.
Goldman Sachs downgraded the previous rating for Artisan Partners Asset Management Inc (NYSE:APAM) from Neutral to Sell. For the fourth quarter, Artisan Partners Asset had an EPS of $0.65, compared to year-ago quarter EPS of $1.29. At the moment, the stock has a 52-week-high of $40.68 and a 52-week-low of $25.66. Artisan Partners Asset closed at $32.78 at the end of the last trading period.
According to William Blair, the prior rating for Qualtrics International Inc (NASDAQ:XM) was changed from Outperform to Market Perform. In the fourth quarter, Qualtrics International showed an EPS of $0.03, compared to $0.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of $30.95 and a 52-week-low of $9.32. Qualtrics International closed at $17.26 at the end of the last trading period.
According to Keybanc, the prior rating for Black Stone Minerals LP (NYSE:BSM) was changed from Overweight to Sector Weight. In the fourth quarter, Black Stone Minerals showed an EPS of $0.82, compared to $0.60 from the year-ago quarter. The stock has a 52-week-high of $20.24 and a 52-week-low of $11.43. At the end of the last trading period, Black Stone Minerals closed at $15.84.
See all analyst ratings downgrades.
Initiations
Wolfe Research initiated coverage on Enlight Renewable Energy Ltd (NASDAQ:ENLT) with an Outperform rating. The price target for Enlight Renewable Energy is set to $21.00. The stock has a 52-week-high of $18.49 and a 52-week-low of $15.38. At the end of the last trading period, Enlight Renewable Energy closed at $16.02.
With a Buy rating, Canaccord Genuity initiated coverage on Perrigo Co PLC (NYSE:PRGO). The price target seems to have been set at $49.00 for Perrigo. For the fourth quarter, Perrigo had an EPS of $0.75, compared to year-ago quarter EPS of $0.60. The stock has a 52-week-high of $43.90 and a 52-week-low of $30.78. At the end of the last trading period, Perrigo closed at $36.96.
With a Hold rating, Jefferies initiated coverage on Lexicon Pharmaceuticals Inc (NASDAQ:LXRX). The price target seems to have been set at $3.00 for Lexicon Pharmaceuticals. In the fourth quarter, Lexicon Pharmaceuticals showed an EPS of $0.16, compared to $0.17 from the year-ago quarter. At the moment, the stock has a 52-week-high of $3.48 and a 52-week-low of $1.31. Lexicon Pharmaceuticals closed at $2.60 at the end of the last trading period.
With a Buy rating, Ladenburg Thalmann initiated coverage on Adverum Biotechnologies Inc (NASDAQ:ADVM). The price target seems to have been set at $2.00 for Adverum Biotechnologies. For the third quarter, Adverum Biotechnologies had an EPS of $0.40, compared to year-ago quarter EPS of $0.39. The stock has a 52-week-high of $1.82 and a 52-week-low of $0.53. At the end of the last trading period, Adverum Biotechnologies closed at $0.77.
JP Morgan initiated coverage on Enlight Renewable Energy Ltd (NASDAQ:ENLT) with an Overweight rating. The price target for Enlight Renewable Energy is set to $23.00. At the moment, the stock has a 52-week-high of $18.49 and a 52-week-low of $15.38. Enlight Renewable Energy closed at $16.02 at the end of the last trading period.
WestPark Capital initiated coverage on Qualys Inc (NASDAQ:QLYS) with a Buy rating. The price target for Qualys is set to $170.00. In the fourth quarter, Qualys showed an EPS of $1.01, compared to $0.84 from the year-ago quarter. The current stock performance of Qualys shows a 52-week-high of $162.36 and a 52-week-low of $101.10. Moreover, at the end of the last trading period, the closing price was at $121.30.
For Mineralys Therapeutics Inc (NASDAQ:MLYS), Evercore ISI Group initiated coverage, by setting the current rating at Outperform. At the moment, the stock has a 52-week-high of $21.98 and a 52-week-low of $17.00. Mineralys Therapeutics closed at $18.96 at the end of the last trading period.
Wells Fargo initiated coverage on Mineralys Therapeutics Inc (NASDAQ:MLYS) with an Overweight rating. The price target for Mineralys Therapeutics is set to $27.00. The current stock performance of Mineralys Therapeutics shows a 52-week-high of $21.98 and a 52-week-low of $17.00. Moreover, at the end of the last trading period, the closing price was at $18.96.
With an Outperform rating, Credit Suisse initiated coverage on Enlight Renewable Energy Ltd (NASDAQ:ENLT). The price target seems to have been set at $22.00 for Enlight Renewable Energy. At the moment, the stock has a 52-week-high of $18.49 and a 52-week-low of $15.38. Enlight Renewable Energy closed at $16.02 at the end of the last trading period.
With an Outperform rating, Credit Suisse initiated coverage on Mineralys Therapeutics Inc (NASDAQ:MLYS). The price target seems to have been set at $40.00 for Mineralys Therapeutics. The current stock performance of Mineralys Therapeutics shows a 52-week-high of $21.98 and a 52-week-low of $17.00. Moreover, at the end of the last trading period, the closing price was at $18.96.
Compass Point initiated coverage on Upstart Holdings Inc (NASDAQ:UPST) with a Sell rating. The price target for Upstart Hldgs is set to $6.00. For the fourth quarter, Upstart Hldgs had an EPS of $0.25, compared to year-ago quarter EPS of $0.89. At the moment, the stock has a 52-week-high of $151.67 and a 52-week-low of $12.01. Upstart Hldgs closed at $18.60 at the end of the last trading period.
Guggenheim initiated coverage on Mineralys Therapeutics Inc (NASDAQ:MLYS) with a Buy rating. The price target for Mineralys Therapeutics is set to $32.00. The stock has a 52-week-high of $21.98 and a 52-week-low of $17.00. At the end of the last trading period, Mineralys Therapeutics closed at $18.96.
With a Buy rating, B of A Securities initiated coverage on Mineralys Therapeutics Inc (NASDAQ:MLYS). The price target seems to have been set at $39.00 for Mineralys Therapeutics. At the moment, the stock has a 52-week-high of $21.98 and a 52-week-low of $17.00. Mineralys Therapeutics closed at $18.96 at the end of the last trading period.
With a Buy rating, Roth MKM initiated coverage on Tenax Therapeutics Inc (NASDAQ:TENX). The price target seems to have been set at $6.00 for Tenax Therapeutics. For the third quarter, Tenax Therapeutics had an EPS of $2.20, compared to year-ago quarter EPS of $3.00. At the moment, the stock has a 52-week-high of $17.00 and a 52-week-low of $0.63. Tenax Therapeutics closed at $0.65 at the end of the last trading period.
EF Hutton initiated coverage on AERWINS Technologies Inc (NASDAQ:AWIN) with a Buy rating. The price target for AERWINS Technologies is set to $2.00. At the moment, the stock has a 52-week-high of $7.25 and a 52-week-low of $0.99. AERWINS Technologies closed at $1.06 at the end of the last trading period.
Baird initiated coverage on CRISPR Therapeutics AG (NASDAQ:CRSP) with a Neutral rating. The price target for CRISPR Therapeutics is set to $46.00. In the fourth quarter, CRISPR Therapeutics showed an EPS of $1.41, compared to $1.84 from the year-ago quarter. The stock has a 52-week-high of $86.95 and a 52-week-low of $38.94. At the end of the last trading period, CRISPR Therapeutics closed at $49.33.
With an Outperform rating, Baird initiated coverage on bluebird bio Inc (NASDAQ:BLUE). The price target seems to have been set at $10.00 for bluebird bio. In the third quarter, bluebird bio showed an EPS of $0.94, compared to $3.16 from the year-ago quarter. At the moment, the stock has a 52-week-high of $8.58 and a 52-week-low of $2.87. bluebird bio closed at $4.90 at the end of the last trading period.
Goldman Sachs initiated coverage on Arista Networks Inc (NYSE:ANET) with a Buy rating. For the fourth quarter, Arista Networks had an EPS of $1.41, compared to year-ago quarter EPS of $0.82. The current stock performance of Arista Networks shows a 52-week-high of $145.17 and a 52-week-low of $89.11. Moreover, at the end of the last trading period, the closing price was at $142.58.
Goldman Sachs initiated coverage on Juniper Networks Inc (NYSE:JNPR) with a Buy rating. Juniper Networks earned $0.65 in the fourth quarter, compared to $0.56 in the year-ago quarter. The stock has a 52-week-high of $38.14 and a 52-week-low of $25.18. At the end of the last trading period, Juniper Networks closed at $31.33.
Goldman Sachs initiated coverage on Cisco Systems Inc (NASDAQ:CSCO) with a Neutral rating. Cisco Systems earned $0.88 in the second quarter, compared to $0.84 in the year-ago quarter. At the moment, the stock has a 52-week-high of $56.94 and a 52-week-low of $38.60. Cisco Systems closed at $49.42 at the end of the last trading period.
For F5 Inc (NASDAQ:FFIV), Goldman Sachs initiated coverage, by setting the current rating at Neutral. F5 earned $2.47 in the first quarter, compared to $2.89 in the year-ago quarter. The stock has a 52-week-high of $217.41 and a 52-week-low of $133.68. At the end of the last trading period, F5 closed at $145.17.
Stifel initiated coverage on Mineralys Therapeutics Inc (NASDAQ:MLYS) with a Buy rating. The price target for Mineralys Therapeutics is set to $45.00. At the moment, the stock has a 52-week-high of $21.98 and a 52-week-low of $17.00. Mineralys Therapeutics closed at $18.96 at the end of the last trading period.
Piper Sandler initiated coverage on Allakos Inc (NASDAQ:ALLK) with an Overweight rating. The price target for Allakos is set to $22.00. For the fourth quarter, Allakos had an EPS of $0.50, compared to year-ago quarter EPS of $1.73. At the moment, the stock has a 52-week-high of $8.73 and a 52-week-low of $2.54. Allakos closed at $5.40 at the end of the last trading period.